FDA Approves Antidepressant "Black Box" Class Labeling
This article was originally published in The Pink Sheet Daily
Executive Summary
The revised labeling should be available on manufacturers' web pages within two weeks and on all products within 30 days, FDA says. Medication Guides should be available to pharmacists by Jan. 31, the agency says.
You may also be interested in...
GSK Amends Paxil Label With Increased Risk of Suicide Warning In Young Adults
Meta-analysis finds that paroxetine-treated patients ages 18-24 have an increased risk of suicidality.
GSK Amends Paxil Label With Increased Risk of Suicide Warning In Young Adults
Meta-analysis finds that paroxetine-treated patients ages 18-24 have an increased risk of suicidality.
Emsam Antidepressant Patch Approved; April Launch Anticipated
Bristol/Somerset’s product avoids MAOI-class dietary restrictions at the lowest dose.